Mizuho Medy Co Ltd
TSE:4595
Mizuho Medy Co Ltd
Cash Equivalents
Mizuho Medy Co Ltd
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mizuho Medy Co Ltd
TSE:4595
|
Cash Equivalents
¥11.2B
|
CAGR 3-Years
37%
|
CAGR 5-Years
120%
|
CAGR 10-Years
N/A
|
|
|
Terumo Corp
TSE:4543
|
Cash Equivalents
¥212.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
|
Olympus Corp
TSE:7733
|
Cash Equivalents
¥220.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
0%
|
|
|
Sysmex Corp
TSE:6869
|
Cash Equivalents
¥81.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
|
Nihon Kohden Corp
TSE:6849
|
Cash Equivalents
¥29B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
|
JEOL Ltd
TSE:6951
|
Cash Equivalents
¥32.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
10%
|
|
Mizuho Medy Co Ltd
Glance View
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.
See Also
What is Mizuho Medy Co Ltd's Cash Equivalents?
Cash Equivalents
11.2B
JPY
Based on the financial report for Dec 31, 2024, Mizuho Medy Co Ltd's Cash Equivalents amounts to 11.2B JPY.
What is Mizuho Medy Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
120%
Over the last year, the Cash Equivalents growth was 11%. The average annual Cash Equivalents growth rates for Mizuho Medy Co Ltd have been 37% over the past three years , 120% over the past five years .
You don't have any saved screeners yet